{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "the-chair", "type": "clause", "offset": [28, 37]}], "snippet": "means to appeal a ruling of the Chair.", "samples": [{"hash": "dewJD8EEW8n", "uri": "https://www.hamilton.ca/sites/default/files/2025-02/21-021-consolidation-feb2025.pdf", "label": "www.hamilton.ca", "score": 19.0472812653, "published": false}, {"hash": "42Hy3vmC1a", "uri": "https://www.hamilton.ca/sites/default/files/2024-12/21-021-consolidation-dec2024.pdf", "label": "www.hamilton.ca", "score": 18.7333946228, "published": false}, {"hash": "ECMWVF3Yzj", "uri": "https://pub-hamilton.escribemeetings.com/filestream.ashx?DocumentId=253914", "label": "pub-hamilton.escribemeetings.com", "score": 15.7750205994, "published": false}], "size": 21, "hash": "7c1d43d5dcf2241718fc435e87a52c46", "id": 1}, {"snippet_links": [{"key": "licensed-patent-rights", "type": "clause", "offset": [56, 78]}, {"key": "including-without-limitation", "type": "clause", "offset": [80, 108]}, {"key": "declaratory-judgment-action", "type": "definition", "offset": [123, 150]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [211, 235]}, {"key": "prior-art", "type": "clause", "offset": [248, 257]}, {"key": "pursuant-to", "type": "definition", "offset": [258, 269]}, {"key": "request-for-re", "type": "clause", "offset": [303, 317]}], "snippet": "means any challenge to the [***] or [***] of any of the Licensed Patent Rights, including without limitation: (a) filing a declaratory judgment action in which any of the Licensed Patent Rights is alleged to be invalid or unenforceable; (b) citing prior art pursuant to 35 U.S.C. \u00a7122 or \u00a7301, filing a request for re-examination of any of the Licensed Patent Rights pursuant to 35 U.S.C. \u00a7302 or \u00a7311, filing a [***] of the Licensed Patent Rights pursuant to [***], or filing a [***] of the Licensed Patent Rights pursuant to [***]; or (c) filing or commencing any re-examination, opposition, cancellation, nullity or similar proceeding against any of the Licensed Patent Rights in any country.", "samples": [{"hash": "8uOJzHOzHTg", "uri": "/contracts/8uOJzHOzHTg#challenge", "label": "Multi Target Agreement (Immunogen Inc)", "score": 29.3504447937, "published": true}, {"hash": "jQ42BsHSUjC", "uri": "/contracts/jQ42BsHSUjC#challenge", "label": "Multi Target Agreement (Immunogen Inc)", "score": 26.6290206909, "published": true}, {"hash": "lx8WD6CW45F", "uri": "/contracts/lx8WD6CW45F#challenge", "label": "Multi Target Agreement (Immunogen Inc)", "score": 23.773443222, "published": true}], "size": 13, "hash": "aa9f25e9d9612e60c102fbee3d8d68f5", "id": 2}, {"snippet_links": [{"key": "an-appeal", "type": "clause", "offset": [6, 15]}, {"key": "the-chair", "type": "clause", "offset": [31, 40]}], "snippet": "means an appeal of a ruling of the Chair.", "samples": [{"hash": "k8ooBQYnkkE", "uri": "https://cityofgp.com/sites/default/files/2022-10/bc1299%20Office%20Consolidation.pdf", "label": "cityofgp.com", "score": 17.7093009949, "published": false}, {"hash": "74JPzpShBFv", "uri": "https://cityofgp.com/sites/default/files/2022-11/bc1299%20Office%20Consolidation.pdf", "label": "cityofgp.com", "score": 17.6079540253, "published": false}, {"hash": "5q3IpctWaMo", "uri": "https://cityofgp.com/sites/default/files/2023-05/bc1299%20Office%20Consolidation.pdf", "label": "cityofgp.com", "score": 11.6652975082, "published": false}], "size": 12, "hash": "6fa0f9aaec4dd7e3fced350bae171d6c", "id": 3}, {"snippet_links": [{"key": "a-proposal", "type": "clause", "offset": [19, 29]}, {"key": "the-department", "type": "clause", "offset": [43, 57]}, {"key": "for-funding", "type": "clause", "offset": [58, 69]}], "snippet": "means a contest to a proposal submitted to the department for funding on the", "samples": [{"hash": "aB8PvxczUGL", "uri": "https://archive.legmt.gov/bills/2023/AmdHtmS/SB0531.004.001.pdf", "label": "archive.legmt.gov", "score": 17.5181388855, "published": false}, {"hash": "5E00yxhG0BY", "uri": "https://archive.legmt.gov/bills/2023/AmdPublicWeb/SB0531.002.002_Amendments-in-Context_final-full.pdf", "label": "archive.legmt.gov", "score": 16.9909534454, "published": false}, {"hash": "3ZAu1A7znj4", "uri": "https://leg.mt.gov/bills/2023/billpdf/SB0531.pdf", "label": "leg.mt.gov", "score": 16.9503993988, "published": false}], "size": 10, "hash": "ed50f3749edff4034daf15a759968990", "id": 4}, {"snippet_links": [{"key": "section-124", "type": "clause", "offset": [36, 48]}], "snippet": "shall have the meaning set forth in Section 12.4.", "samples": [{"hash": "58MMvN6N4qo", "uri": "/contracts/58MMvN6N4qo#challenge", "label": "License and Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "bq6qqJEYs6g", "uri": "/contracts/bq6qqJEYs6g#challenge", "label": "Research Collaboration and License Agreement (Arcturus Therapeutics Ltd.)", "score": 29.3641338348, "published": true}, {"hash": "7WuQDcjFFxx", "uri": "/contracts/7WuQDcjFFxx#challenge", "label": "License and Collaboration Agreement (Planet Alpha Corp.)", "score": 28.6824092865, "published": true}], "size": 10, "hash": "603d597d2fab41614b6529d1ffe38051", "id": 5}, {"snippet_links": [], "snippet": "has the meaning set forth in Section 13.19(a).", "samples": [{"hash": "IExZOwDUzN", "uri": "/contracts/IExZOwDUzN#challenge", "label": "Partnership Agreement", "score": 31.3408622742, "published": true}, {"hash": "3hVkYw8XOuO", "uri": "/contracts/3hVkYw8XOuO#challenge", "label": "Partnership Agreement", "score": 31.3408622742, "published": true}, {"hash": "gKxCTRePZ0O", "uri": "/contracts/gKxCTRePZ0O#challenge", "label": "Partnership Agreement (Newmark Group, Inc.)", "score": 28.9644088745, "published": true}], "size": 9, "hash": "6f43b66ba8409fa9e819700fbf08d8d5", "id": 6}, {"snippet_links": [{"key": "a-dispute", "type": "definition", "offset": [6, 15]}], "snippet": "means a dispute regarding a scheduled and validated video session.", "samples": [{"hash": "lsSVu1S280r", "uri": "https://www.legis.iowa.gov/docs/iac/agency/02-01-2017.751.pdf", "label": "www.legis.iowa.gov", "score": 9.2740497589, "published": false}, {"hash": "b6g1IYjCUTm", "uri": "https://www.legis.iowa.gov/docs/iac/agency/02-26-2020.751.pdf", "label": "www.legis.iowa.gov", "score": 7.308008194, "published": false}, {"hash": "lsSVu1S280r", "uri": "https://www.legis.iowa.gov/docs/iac/agency/07-04-2018.751.pdf", "label": "www.legis.iowa.gov", "score": 6.1375770569, "published": false}], "size": 8, "hash": "3094cbf5b058bdcffa37611366cbe19a", "id": 7}, {"snippet_links": [{"key": "procurement-proceedings", "type": "definition", "offset": [21, 44]}, {"key": "terms-of", "type": "definition", "offset": [56, 64]}], "snippet": "means a challenge to procurement proceedings brought in terms of Part X;", "samples": [{"hash": "k46JgD84wNT", "uri": "https://zimlii.org/akn/zw/act/2017/5/eng@2018-01-01/source.pdf", "label": "zimlii.org", "score": 18.8837432861, "published": false}, {"hash": "fGZAL7NM2rc", "uri": "https://zimlii.org/akn/zw/act/2017/5/eng@2020-02-07/source.pdf", "label": "zimlii.org", "score": 18.800151825, "published": false}, {"hash": "30IyKgzLTuH", "uri": "https://media.zimlii.org/files/legislation/akn-zw-act-2017-5-eng-2020-02-07.pdf", "label": "media.zimlii.org", "score": 11.1793289185, "published": false}], "size": 8, "hash": "9db257bd4b32d4b297352cfb1d5ed423", "id": 8}, {"snippet_links": [{"key": "licensor-patents", "type": "definition", "offset": [68, 84]}, {"key": "including-without-limitation", "type": "clause", "offset": [86, 114]}, {"key": "declaratory-judgment-action", "type": "definition", "offset": [131, 158]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [213, 237]}, {"key": "similar-proceedings", "type": "clause", "offset": [387, 406]}, {"key": "patent-offices", "type": "definition", "offset": [460, 474]}], "snippet": "means any challenge to the validity or enforceability of any of the Licensor Patents, including without limitation by (a) filing a declaratory judgment action in which any of the Licensor Patents is alleged to be invalid or unenforceable; or (b) filing or commencing any re-examination, interference, derivation proceeding, post-issuance proceeding, opposition, cancellation, nullity or similar proceedings against any of the Licensor Patents in the courts or patent offices in any country.", "samples": [{"hash": "gidcnacw4NY", "uri": "/contracts/gidcnacw4NY#challenge", "label": "License Agreement", "score": 31.3408622742, "published": true}, {"hash": "iRvjqoHJzUC", "uri": "/contracts/iRvjqoHJzUC#challenge", "label": "Technology License and Collaboration Agreement (Aridis Pharmaceuticals, Inc.)", "score": 29.7337436676, "published": true}, {"hash": "7kgNqrhzqIu", "uri": "/contracts/7kgNqrhzqIu#challenge", "label": "Technology License and Collaboration Agreement (Aridis Pharmaceuticals, Inc.)", "score": 29.5420951843, "published": true}], "size": 8, "hash": "6081e2741d122ac6c83ee418ef881530", "id": 9}, {"snippet_links": [], "snippet": "means any challenge to a sanction decision, i.e. it embraces \u2018decision reviews\u2019, \u2018mandatory reconsiderations\u2019 and Tribunal appeals.", "samples": [{"hash": "3VwbcLDFrRS", "uri": "https://www.freit.org/WorkingPapers/Papers/Other/FREIT1786.pdf", "label": "www.freit.org", "score": 9.3846683502, "published": false}, {"hash": "gqzhiZzqoQV", "uri": "https://cpag.org.uk/sites/default/files/uploads/16-05%20Sanctions%20Stats%20Briefing%20-%20D%20Webster%2031%20May%202016.docx", "label": "cpag.org.uk", "score": 6.2142367363, "published": false}, {"hash": "igloijVbzPi", "uri": "https://www.rightsnet.org.uk/?ACT=39&fid=5&aid=1106_g4q3TyqS7SIuGvH6eA1D&board_id=1", "label": "www.rightsnet.org.uk", "score": 5.9582476616, "published": false}], "size": 7, "hash": "5f1e90cf339948b0248d82823502f8ab", "id": 10}], "next_curs": "ClYSUGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjILEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiISY2hhbGxlbmdlIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Challenge", "snippet": "means to appeal a ruling of the Chair.", "size": 504, "id": "challenge", "examples": ["Licensee understands and agrees that, in the event Licensee (or its Affiliate or Sublicensee) successfully brings or participates as an adverse party in any Patent <strong>Challenge</strong>, all payments or other consideration made or otherwise provided by Licensee to MD \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 prior to a final, non-appealable adjudication of such Patent <strong>Challenge</strong> shall be non-refundable.", "To the extent that Licensee (or its Affiliate or Sublicensee) unsuccessfully brings or participates as an adverse party in any Patent <strong>Challenge</strong> (except as required under a court order or subpoena), Licensee agrees to reimburse MD \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 and Board for all costs and fees (including attorney\u2019s fees) paid by MD \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 and Board in defending against such <strong>challenge</strong>."], "related": [["contest", "Contest", "Contest"], ["complaint-investigation", "Complaint Investigation", "Complaint Investigation"], ["patent-challenge", "Patent Challenge", "Patent <strong>Challenge</strong>"], ["threatened-litigation", "Threatened litigation", "Threatened litigation"], ["legal-action", "Legal Action", "Legal Action"]], "related_snippets": [], "updated": "2026-06-04T04:23:11+00:00"}, "json": true, "cursor": ""}}